4//SEC Filing
Chu Yu-Waye 4
Accession 0001209191-22-003166
CIK 0001434316other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:05 PM ET
Size
7.3 KB
Accession
0001209191-22-003166
Insider Transaction Report
Form 4
Chu Yu-Waye
Senior VP Clinical Development
Transactions
- Sale
Common Stock
2022-01-11$49.10/sh−418$20,524→ 121,793 total - Sale
Common Stock
2022-01-11$48.44/sh−3,547$171,817→ 122,211 total
Footnotes (3)
- [F1]Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 4,503 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through "sell to cover" transactions and do not represent discretionary trades by the reporting person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $47.68 to $48.67 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3.
- [F3]Represents the weighted average sale price of the shares sold ranging from $48.71 to $49.25 per share.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001854586
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:05 PM ET
- Size
- 7.3 KB